We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+13.82%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.5B
AUM Growth
+$378M
Cap. Flow
+$252M
Cap. Flow %
1.74%
Top 10 Hldgs %
26.25%
Holding
735
New
61
Increased
261
Reduced
285
Closed
31

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$73.6M
2
GILD icon
Gilead Sciences
GILD
+$57M
3
MSFT icon
Microsoft
MSFT
+$44.1M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$38.6M
5
NU icon
Nu Holdings
NU
+$38M

Sector Composition

Rank Sector Weight
1 Technology 30.32%
2 Healthcare 28.88%
3 Consumer Discretionary 8.63%
4 Financials 8.52%
5 Industrials 6.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KEYS icon
76
Keysight
KEYS
$53.6B
$47M 0.32%
295,506
+20,556
+7% +$2.79M
MU icon
77
Micron Technology
MU
$1.02T
$46.7M 0.32%
547,523
+67,274
+14% +$5M
PDD icon
78
Pinduoduo
PDD
$121B
$45.7M 0.32%
312,060
-13,940
-4% -$1.69M
VEEV icon
79
Veeva Systems
VEEV
$31.6B
$45.3M 0.31%
235,161
+61,549
+35% +$11.6M
SNPS icon
80
Synopsys
SNPS
$74.5B
$45.1M 0.31%
87,678
-5,550
-6% -$2.84M
HLT icon
81
Hilton Worldwide
HLT
$75.3B
$45.1M 0.31%
247,422
+8,553
+4% +$1.4M
CRWD icon
82
CrowdStrike
CRWD
$183B
$44.6M 0.31%
698,988
+31,580
+5% +$1.65M
MDLZ icon
83
Mondelez International
MDLZ
$77.9B
$42.6M 0.29%
588,376
-208,315
-26% -$14.3M
BNY
84
Bank of New York Mellon
BNY
$107B
$42M 0.29%
806,764
+40,786
+5% +$1.88M
ZTS icon
85
Zoetis
ZTS
$32.2B
$41.7M 0.29%
211,172
+166,731
+375% +$29.5M
LULU icon
86
lululemon athletica
LULU
$13.4B
$40.4M 0.28%
78,958
-3,267
-4% -$1.41M
NU icon
87
Nu Holdings
NU
$70.2B
$39.1M 0.27%
+4,696,438
New +$38M
OLED icon
88
Universal Display
OLED
$3.81B
$38.1M 0.26%
199,228
+10,056
+5% +$1.66M
QCOM icon
89
Qualcomm
QCOM
$179B
$37.5M 0.26%
259,192
+69,264
+36% +$8.58M
FSLR icon
90
First Solar
FSLR
$22.1B
$36.6M 0.25%
212,420
+123,747
+140% +$18.9M
DAR icon
91
Darling Ingredients
DAR
$9.62B
$36.5M 0.25%
732,739
+11,661
+2% +$529K
MRNA icon
92
Moderna
MRNA
$22.1B
$36.1M 0.25%
363,044
-79,316
-18% -$6.67M
BZ icon
93
Kanzhun
BZ
$7.03B
$35.8M 0.25%
2,157,254
+765,124
+55% +$12M
FTV icon
94
Fortive
FTV
$19.2B
$35.1M 0.24%
632,734
+117,510
+23% +$6.2M
SLB icon
95
SLB Ltd
SLB
$76.5B
$35M 0.24%
672,485
+45,123
+7% +$2.45M
ABBV icon
96
AbbVie
ABBV
$454B
$34.2M 0.24%
220,652
+8,839
+4% +$1.29M
CVS icon
97
CVS Health
CVS
$137B
$34.2M 0.24%
432,613
+173,041
+67% +$12.3M
HUM icon
98
Humana
HUM
$45.8B
$33.5M 0.23%
73,104
+11,356
+18% +$5.6M
IMGN
99
DELISTED
Immunogen Inc
IMGN
$33.3M 0.23%
1,122,598
+10
+0% +$199
KROS icon
100
Keros Therapeutics
KROS
$202M
$32.6M 0.22%
819,062
+78,001
+11% +$2.45M

Similar funds

Candriam SCA's Q4 2023 Portfolio in Review

As of Q4 2023, Candriam SCA held 735 positions worth $14.5B, up 2.7% from $14.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Candriam SCA's Q4 2023 filing shows 61 new, 261 increased, 285 reduced and 31 closed positions. Its largest new stake was Nu Holdings: 4,696,438 shares worth $39.1M. The largest sale was Seagen Inc. Common Stock, an estimated $112M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Candriam SCA's largest Q4 2023 buy was Nu Holdings: 4,696,438 shares worth $39.1M.
  • Candriam SCA added most to Visa in Q4 2023, an estimated $73.6M increase.
  • Candriam SCA's biggest Q4 2023 reduction was Royal Bank of Canada, cutting an estimated $44.3M.
  • Candriam SCA fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $112M.
  • Candriam SCA's ten largest holdings make up 26% of its $14.5B portfolio in Q4 2023.
  • Candriam SCA opened 61 new positions and closed 31 in Q4 2023.
  • Candriam SCA's portfolio value rose 2.7% quarter-over-quarter to $14.5B.

Based on Candriam SCA's 13F filing for Q4 2023, filed 14 Feb 2024.